RT
Rezo Therapeutics, Inc.
SEC filingBiotechnology · San Francisco, CA
Amount raised$68.1Msold at filing
Total offering$80.1M$12.1M still open
Investors in the raise21count reported to the SEC
FiledAug 18, 2025first sale Jul 21, 2022
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Simeon GeorgeDirector
Derek HicksExecutive Officer, Director
Nevan KroganExecutive Officer, Director
Tiba AynechiDirector
Jennifer ChangExecutive Officer
George ScangosDirector
Norbert BischofbergerDirector
Vineeta AgarwalaDirector
Executive officers, directors and promoters as listed on the Form D.